Compare ORIC & VREX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ORIC | VREX |
|---|---|---|
| Founded | 2014 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 837.3M | 501.8M |
| IPO Year | 2020 | 2016 |
| Metric | ORIC | VREX |
|---|---|---|
| Price | $10.14 | $12.31 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 13 | 3 |
| Target Price | ★ $19.73 | $16.67 |
| AVG Volume (30 Days) | ★ 2.5M | 208.5K |
| Earning Date | 05-05-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 19.67 | N/A |
| EPS | N/A | ★ 0.05 |
| Revenue | N/A | ★ $811,000,000.00 |
| Revenue This Year | N/A | $5.35 |
| Revenue Next Year | N/A | $3.88 |
| P/E Ratio | ★ N/A | $245.90 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $4.52 | $6.76 |
| 52 Week High | $14.93 | $14.57 |
| Indicator | ORIC | VREX |
|---|---|---|
| Relative Strength Index (RSI) | 46.38 | 66.18 |
| Support Level | $9.59 | $12.00 |
| Resistance Level | $10.31 | $12.61 |
| Average True Range (ATR) | 0.63 | 0.33 |
| MACD | 0.10 | 0.18 |
| Stochastic Oscillator | 63.75 | 92.72 |
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.
Varex Imaging Corp Designs, manufactures, sells, and services X-ray imaging components, including X-ray tubes, detectors, ionization chambers, high-voltage connectors, software, collimators, generators, exposure control devices, and heat exchangers.. The company operates through two segments: Medical, the key revenue driver, providing X-ray imaging components and accessories for healthcare applications, and Industrial, which provides Linatron X-ray accelerators, X-ray tubes, flat panel detectors, high-voltage connectors, and coolers for non-medical use. Geographically, it generates the majority of its revenue from Europe, the Middle East, and Africa (EMEA), with the rest coming from the Americas and Asia Pacific.